[METAvivor](https://www.metavivor.org)

March 2026 (Letter of Intent) | August 2026 (Invited full application & internal submission) | December 2026 (Funding organization's deadline)

Up to $200,000 total over two years; includes direct costs (with up to $3,000 for travel) and up to 5% indirect costs.

Supports innovative research by early-career investigators to advance treatment and understanding of metastatic breast cancer.

--- ## Description This award supports promising early-career investigators conducting novel, high-quality research in metastatic (stage IV) breast cancer. The program aims to fund basic, translational, and clinical research that addresses critical challenges or barriers in the field, with an emphasis on projects likely to benefit patients living with metastatic disease. Preference is given to studies focused on established metastases, mechanistic insights, or pre-clinical animal research that could lead to improved clinical outcomes or lay the groundwork for future treatment advances. Projects focused solely on prevention or diagnosis (except for novel diagnostic tools monitoring metastatic progression) are not eligible. The award is designed to help early-stage researchers establish a foundation for future work in metastatic breast cancer. --- ## Due Dates - March 2026: Letter of Intent deadline (anticipated/projected) - August 2026: Invited full application deadline (anticipated/projected) - August 2026: Internal submission deadline (anticipated/projected) - December 2026: Funding organization's deadline (anticipated/projected) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Up to $200,000 total over two years. - Direct costs, including up to $3,000 (over two years) for travel. - Indirect costs allowed up to 5% of the total award. --- ## Eligibility - Early-career investigators: within 10 years of receiving a doctoral degree and, if applicable, within 6 years of starting their first non-tenured faculty position. - Applicants must be actively engaged in metastatic breast cancer research and treatment. - Research must focus on established metastatic breast cancer (stage IV) and demonstrate potential for direct patient benefit. - Only one application per applicant is permitted. - Projects focused solely on prevention or diagnosis (unless involving novel tools for monitoring metastasis) are not eligible. - Applications with overlapping scope/aims cannot be submitted by the same PI to both Early Career and Translational Research Award programs. --- ## Application Process - Submit a Letter of Intent (LOI) by the anticipated March deadline. - LOIs are peer- and advocate-reviewed; approximately 30% of applicants will be invited to submit a full application. - Invited full applications are due in August (anticipated). - Applications undergo further review by scientific peers, patient advocates, and the Scientific Advisory Board before final funding decisions. - All submissions must be made through the [METAvivor Grant Portal](https://metavivor.infoready4.com/#homePage). --- ## Additional Information - The grant program is highly competitive, with a rigorous two-stage review process. - The focus is exclusively on metastatic breast cancer; proposals must clearly articulate relevance to established metastases. - The number of awards made each year depends on available funding. --- ## External Links - [Program Overview & Application Portal](https://metavivor.infoready4.com/#competitionDetail/1963843) - [Funder Home Page](https://www.metavivor.org) - [Grant Process Overview](https://metavivor.org/research/our-grant-process/) - [Apply for a Grant](https://metavivor.org/research/apply-for-a-grant/) --- ## Contact Information | Contact | Email | Web Contact Form | |------------------------|------------------------------|----------------------------------------------------------| | METAvivor Grants Team | info@metavivor.org | [Contact METAvivor](https://www.metavivor.org/about-us/contact-us/) |

2025 Early Career Investigator Award

Sign in to see full grant listing